These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7881027)

  • 1. Dynamism of cytoprotective and antisecretory drugs in patients with unhealed gastric and duodenal ulcers.
    Mózsik G; Hunyady B; Garamszegi M; Németh A; Pakodi F; Vincze A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S88-92. PubMed ID: 7881027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative dynamic study of the effectiveness of gastric cytoprotection by vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (a multiclinical and randomized study).
    Patty I; Tárnok F; Simon L; Jávor T; Deák G; Benedek S; Kenéz P; Nagy L; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):379-84. PubMed ID: 6397969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotective effect of vitamin A and its clinical importance in the treatment of patients with chronic gastric ulcer.
    Patty I; Benedek S; Deák G; Jávor T; Kenéz P; Morón F; Nagy L; Simon L; Tárnok F; Mózsik G
    Int J Tissue React; 1983; 5(3):301-7. PubMed ID: 6654626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous evaluation of gastric and duodenal ulcers-healing activities of anti-ulcer agents in rats.
    Segami T; Suzuki Y; Ito M
    Biol Pharm Bull; 1996 Jan; 19(1):53-6. PubMed ID: 8820911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Ardizzone S; Manzionna G; Caruso I; Montrone F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):343-7. PubMed ID: 9690723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer].
    Grinevich VB; Uspenskiĭ IuP; Shabanova GZh; Sablin OA; Shcherbina NN
    Klin Med (Mosk); 2002; 80(10):44-6. PubMed ID: 12471838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients.
    Battaglia G; Di Mario F; Dotto P; Leandro G; Pilotto A; Ferrana M; Vianello F; Vigneri S; Colonna CV; Naccarato R
    Dig Dis Sci; 1993 Aug; 38(8):1414-21. PubMed ID: 8344096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled comparison of sucralfate and cimetidine in duodenal ulcer.
    Hentschel E; Schütze K; Dufek W
    Scand J Gastroenterol Suppl; 1983; 83():31-5. PubMed ID: 6356318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric ulcer: a double-blind comparison of 100 mg pirenzepine plus antacid versus 800 mg cimetidine plus antacid.
    Gonvers JJ; Realini S; Bretholz A; Voirol M; Arnold J; Birchler R; Ollyo JB; Guyot J; Capitaine Y
    Scand J Gastroenterol; 1986 Sep; 21(7):806-8. PubMed ID: 3535007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do ulcers heal with sucralfate?
    Lam SK
    Scand J Gastroenterol Suppl; 1990; 173():6-16. PubMed ID: 2190306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcers. A multicenter study.
    Pop P; Nikkels RE; Thys O; Dorrestein GC
    Scand J Gastroenterol Suppl; 1983; 83():43-7. PubMed ID: 6356320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healing of gastric body ulcer with gastroprotective versus antisecretory treatment.
    Jablonská M
    Dig Dis Sci; 1995 Sep; 40(9):2016-8. PubMed ID: 7555458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
    Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
    Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antacid therapy for duodenal and gastric ulcer: the experience in the United States.
    Ippoliti AF
    Scand J Gastroenterol Suppl; 1982; 75():82-5. PubMed ID: 6755655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirenzepine in long-term therapy for duodenal ulcer.
    Capria A; Bresci G; Polloni A; Rindi G; Geloni M; Del Tacca M
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):422-4. PubMed ID: 6688799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers.
    Hoetzinger H
    Pharmatherapeutica; 1985; 4(3 Spec No):155-60. PubMed ID: 3903784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acid anti-secretion therapy in gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1981 Oct; 99(2):187-205. PubMed ID: 6119184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.